Dual-purpose vardenafil hydrochloride/dapoxetine hydrochloride orodispersible tablets: in vitro formulation/evaluation, stability study and in vivo comparative pharmacokinetic study in healthy human subjects

References

• Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996;8:47–52.
   PubMedGoogle Scholar
• Levine SB, Althof SE, Turner LA, et al. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J Urol. 1989;141:54–57.
   PubMed Web of Science ®Google Scholar
• Fries R, Shariat K, von Wilmowsky H, et al. Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapy. Circulation. 2005;112:2980–2985.
   PubMed Web of Science ®Google Scholar
• Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13:192–199.
   PubMed Web of Science ®Google Scholar
• Rosen R, Shabsigh R, Berber M, et al. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry. 2006;163:79–87.
   PubMed Web of Science ®Google Scholar
• Rajagopalan P, Mazzu A, Xia C, et al. Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. J Clin Pharmacol. 2003;43:260–267.
   PubMed Web of Science ®Google Scholar
• Rosenberg MT, Adams PL, McBride TA, et al. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study. Int J Clin Pract. 2009;63:27–34.
   PubMed Web of Science ®Google Scholar
• Pfister WR, Ghosh TK. Orally disintegrating tablets products, technologies, and development issues. Pharm Technol. 2005;29:136–151.
   Google Scholar
• Vonk J, Shackelford TK, editors. The Oxford handbook of comparative evolutionary psychology. New York (NY): Oxford University Press; 2012.
   Google Scholar
• Abdel-Moety MM, Souaya ER, Soliman EA. Spectrophotometric methods for simultaneous determination of vardenafil and dapoxetine hydrochlorides in combined dosage form. World J Pharm Pharm Sci. 2015;4:120–133.
   Google Scholar
• Kendirci M, Salem E, Hellstrom WJG. Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation. Ther Clin Risk Manag. 2007;3:277.
   PubMedGoogle Scholar
• Giron D. Applications of thermal analysis and coupled techniques in pharmaceutical industry. J Therm Anal Calorim. 2002;68:335–357.
   Web of Science ®Google Scholar
• Pepperberg IM. Grey parrot (Psittacus erithacus) numerical abilities: addition and further experiments on a zero-like concept. J Comp Psychol. 2006;120:1–11.
   PubMed Web of Science ®Google Scholar
• Shamma R. Enhancement of dissolution and bioavailability of nimesulide [Master thesis]. Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2008.
   Google Scholar
• Widjaja B, Setyawan D, Moechtar J. Development of piroxicam orally disintegrating tablets by freeze drying method. Int J Pharm Pharm Sci. 2013;5:795–798.
   Google Scholar
• Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 2009;73:162–171.
   PubMed Web of Science ®Google Scholar
• Abdel HS. Formulation of new sildenafil citrate-caffeine orally disintegrating tablets: in vitro and in vivo evaluation. J Pharm Res Opin. 2013;3:46–63.
   Google Scholar
• Chaudhary SA, Chaudhary AB, Mehta TA. Formulation, development and evaluation of fast disintegrating tablets of rizatriptan benzoate using novel adjuvants. Int J ChemTech Res. 2010;2:1026–1030.
   Google Scholar
• Bhowmik D, Chiranjib B, Yadav J. Emerging trends of disintegrants used in formulation of solid dosage form. Pharm Lett. 2010;2:495–504.
   Google Scholar
• Shah SJ, Mazumder R. Formulation development and evaluation of mouth dissolving tablet of Tramadol hydrochloride. Asian J Pharm Clin Res. 2013;6(suppl3):31–36.
   Google Scholar
• European Pharmacopoeia Commission. Council of Europe. European Pharmacopoeia. Sainte Ruffine (France): Maisonneuve; 2015.
   Google Scholar
• Zayed R, Shukr M, Kamel AO, et al. An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension. Acta Pharm Acta Pharm 2012;62:411–432.
   PubMed Web of Science ®Google Scholar
• Orally disintegrating tablets: formulation development, novel engineering solutions and fixed dose combinations. Doctoral Thesis, Aston University, Birmingham, UK; 2017.
   Google Scholar
• Dennison TJ, Smith JC, Badhan RK, et al. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability. Drug Des Dev Ther. 2017;11:811–826.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12:263–271.
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet 1991;16:249–255.
   PubMed Web of Science ®Google Scholar
• Bala R, Khanna S, Pawar P. Polymers in fast disintegrating tablets – a review. Asian J Pharm Clin Res. 2012;5:8–14.
   Google Scholar
• Ciper M, Bodmeier R. Preparation and characterization of novel fast disintegrating capsules (Fastcaps) for administration in the oral cavity. Int J Pharm. 2005;303:62.
   PubMed Web of Science ®Google Scholar
• Schramm LL, Stasiuk EN, Marangoni DG. 2 Surfactants and their applications. Annu Rep Prog Chem Sect C. 2003;99:3–48.
   Google Scholar
• Sadeghi F, Mosaffa F, Afrasiabi Garekani H. Effect of particle size, compaction force and presence of aerosil 200 on the properties of matrices prepared from physical mixture of propranolol hydrochloride and eudragit RS or RL. Iran J Basic Med Sci. 2007;10:197–205.
   Google Scholar
• Kar R, Mohapatra S, Bhanja S, et al. Formulation and in vitro characterization of xanthan gum-based sustained release matrix tables of isosorbide-5-mononitrate. Iran J Pharm Res. 2010;9:13–19.
   PubMed Web of Science ®Google Scholar
• El-Kamel A, Sokar M, Naggar V, et al. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS J. 2002;4:224–230.
   Google Scholar
• Nikghalb LA, Kahkeshan KF, Singh G, et al. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci. 2012;2:170–175.
   Google Scholar
• Ismail S, El-Mahdy M, Al-Kubati S. Enhancement of solubility and dissolution of nimesulide using solubilization, solid dispersion and complexation techniques. Bull Pharm Sci. 2009;32:321–338.
   Google Scholar
• Lakshmi AP, Meka AK, Krishna MV, et al. Formulation development of irbesartan (poorly water-soluble drug) immediate release tablets. Int Res J Pharm. 2012;3:117–120.
   Google Scholar
• Sanghvi R, Narazaki R, Machatha SG, et al. Solubility improvement of drugs using N-methyl pyrrolidone. AAPS PharmSciTech. 2008;9:366–376.
   PubMed Web of Science ®Google Scholar
• Lannie H, Purnama DL, Fenny M, et al. Liquisolid technique for ibuprofen tablet. Int Res J Pharm. 2013;2:123–127.
   Google Scholar
• Bashiri-Shahroodi A. Dropping method as a new possibility in preparation of solid dispersions. Doctoral dissertation, Allen Institute for Artificial Intelligence, Seattle, WA; 2008.
   Google Scholar
• Rahamathulla M, Hv G, Rathod N. Solubility and dissolution improvement of Rofecoxib using solid dispersion technique. Pak J Pharm Sci. 2008;21:350–355.
   PubMed Web of Science ®Google Scholar
• Ibrahim E, El-Faham T, Mohammed F, et al. Enhancement of solubility and dissolution rate of domperidone by utilizing different techniques. Bull Pharm Sci. 2011;34:105–120.
   Google Scholar
• Li S, Wei B, Fleres S, et al. Correlation and prediction of moisture-mediated dissolution stability for benazepril hydrochloride tablets. Pharm Res. 2004;21:617–624.
   PubMed Web of Science ®Google Scholar
• Debruyne FM, Gittelman M, Sperling H, et al. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. J Sex Med. 2011;8:2912–2923.
   PubMed Web of Science ®Google Scholar
• Berry B, Altman P, Rowe J, et al. Comparison of pharmacokinetics of vardenafil administered using an ultrasonic nebulizer for inhalation vs a single 10-mg oral tablet. J Sex Med. 2016;13:1111–1118.
   PubMed Web of Science ®Google Scholar